Fatty acid desaturases from primula
US-2017283780-A1 · Oct 5, 2017 · US
US11034983B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11034983-B2 |
| Application number | US-201313770929-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 19, 2013 |
| Priority date | Apr 16, 2004 |
| Publication date | Jun 15, 2021 |
| Grant date | Jun 15, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates generally to the expression of desaturase enzymes in transgenic corn plants and compositions derived therefrom. In particular, the invention relates to the production of oils with improved omega-3 fatty acid profiles in corn plants and the seed oils produced thereby. Such oils may contain stearidonic acid, which is not naturally found in corn plants and has been shown to have beneficial effects on health.
Opening claim text (preview).
The invention claimed is: 1. An endogenous corn seed oil having an endogenous stearidonic acid (18:4 n-3) content of from about 5% to about 33% and further endogenously comprising gamma-linolenic acid, wherein the ratio of stearidonic acid to gamma-linolenic acid is at least 3:1. 2. The endogenous corn seed oil of claim 1 , wherein the stearidonic acid content is about 15% to about 32%. 3. The endogenous corn seed oil of claim 1 , wherein the corn seed oil is defined as endogenously comprising gamma-linolenic acid in a content of less than 7.5%. 4. The endogenous corn seed oil of claim 1 , wherein the ratio of stearidonic acid to gamma-linolenic acid is from 3:1 to about 10:1. 5. The endogenous corn seed oil of claim 1 , wherein the ratio of omega-3 to omega-6 fatty acids in the oil is selected from the group consisting of from about 0.5:1 to about 10:1, from about 5:1 to about 10:1, and at least 5:1. 6. The endogenous corn seed oil of claim 1 , wherein the stearidonic acid content is about 10% to about 33%. 7. The endogenous corn seed oil of claim 1 , wherein the stearidonic acid content is about 20% to about 30%. 8. The endogenous corn seed oil of claim 1 , wherein the stearidonic acid content is about 25% to about 30%. 9. The endogenous corn seed oil of claim 1 , wherein the corn seed oil is defined as endogenously comprising gamma-linolenic acid in a content of less than 5%. 10. The endogenous corn seed oil of claim 1 , wherein the corn seed oil is defined as endogenously comprising gamma-linolenic acid in a content of less than 3%. 11. The endogenous corn seed oil of claim 1 , wherein the ratio of stearidonic acid to gamma-linolenic acid is from 3:1 to about 5:1.
Miscellaneous (1.14.99) · CPC title
involving modified lipid metabolism, e.g. seed oil composition · CPC title
Antiasthmatics · CPC title
for joint disorders, e.g. arthritis, arthrosis · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.